(Hypertension. 1997;30:619.)
© 1997 American Heart Association, Inc.
Articles |
Sympathetic and Cardiorenal Actions of Leptin
From the Hypertension Genetics Specialized Center of Research, Cardiovascular Center, Diabetes Endocrine Research Center, and Department of Internal Medicine, University of Iowa College of Medicine and Veterans Affairs Medical Center (Iowa City).
Abstract Body weight is tightly regulated physiologically. The recent discovery of the peptide hormone leptin has permitted more detailed evaluation of the mechanisms responsible for control of body fat. Leptin is almost exclusively produced by adipose tissue and acts in the CNS through a specific receptor and multiple neuropeptide pathways to decrease appetite and increase energy expenditure. Leptin thus functions as the afferent component of a negative feedback mechanism to control adipose tissue mass. Increasing evidence suggests that leptin may have wider actions influencing autonomic, cardiovascular, and endocrine function. Intravenous leptin increases norepinephrine turnover and sympathetic nerve activity to thermogenic brown adipose tissue. Studies from our laboratory suggest that leptin also increases sympathetic nerve activity to kidney, hindlimb, and adrenal gland. However, systemic administration of leptin does not acutely increase arterial pressure or heart rate in anesthetized animals. Thus, longer-term exposure to hyperleptinemia may be necessary for full expression of the expected pressor effect of renal sympathoexcitation. Alternatively, leptin may have additional cardiovascular actions to oppose sympathetically mediated vasoconstriction. Leptin in high doses increases renal sodium and water excretion, apparently through a direct tubular action. In addition, leptin appears to increase systemic insulin sensitivity, even in the absence of weight loss. Although we are at an early stage of understanding, we speculate that abnormalities in the actions of leptin may have implications for the sympathetic, cardiovascular, and renal changes associated with obesity.
Key Words: obesity • adipose tissue • autonomic nervous system • kidney • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  D. Ma, M. F. Feitosa, J. B. Wilk, J. M. Laramie, K. Yu, C. Leiendecker-Foster, R. H. Myers, M. A. Province, and I. B. Borecki Leptin Is Associated With Blood Pressure and Hypertension in Women From the National Heart, Lung, and Blood Institute Family Heart Study Hypertension, March 1, 2009; 53(3): 473 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Greenfield, J. W. Miller, J. M. Keogh, E. Henning, J. H. Satterwhite, G. S. Cameron, B. Astruc, J. P. Mayer, S. Brage, T. C. See, et al. Modulation of Blood Pressure by Central Melanocortinergic Pathways N. Engl. J. Med., January 1, 2009; 360(1): 44 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. do Carmo, J. E. Hall, and A. A. da Silva Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1974 - H1981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, J. M. do Carmo, B. Kanyicska, J. Dubinion, E. Brandon, and J. E. Hall Endogenous Melanocortin System Activity Contributes to the Elevated Arterial Pressure in Spontaneously Hypertensive Rats Hypertension, April 1, 2008; 51(4): 884 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Fink, J. A. Herlein, K. Almind, S. Cinti, C. R. Kahn, and W. I. Sivitz Mitochondrial proton leak in obesity-resistant and obesity-prone mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1773 - R1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension Hypertension, November 1, 2007; 50(5): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Levinger, C. Goodman, D. L. Hare, G. Jerums, and S. Selig The Effect of Resistance Training on Functional Capacity and Quality of Life in Individuals with High and Low Numbers of Metabolic Risk Factors Diabetes Care, September 1, 2007; 30(9): 2205 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Levin Why some of us get fat and what we can do about it J. Physiol., September 1, 2007; 583(2): 425 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Knudson, G. M. Dick, and J. D. Tune Adipokines and Coronary Vasomotor Dysfunction Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Gorski, A. A. Dunn-Meynell, and B. E. Levin Maternal obesity increases hypothalamic leptin receptor expression and sensitivity in juvenile obesity-prone rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1782 - R1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Penn, L. C. Jordan, E. W. Kelso, J. E. Davenport, and R. B. S. Harris Effects of central or peripheral leptin administration on norepinephrine turnover in defined fat depots Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1613 - R1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, L. S. Tallam, J. Liu, and J. E. Hall Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1275 - R1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esler, N. Straznicky, N. Eikelis, K. Masuo, G. Lambert, and E. Lambert Mechanisms of Sympathetic Activation in Obesity-Related Hypertension Hypertension, November 1, 2006; 48(5): 787 - 796. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Trayhurn and C. Bing Appetite and energy balance signals from adipocytes Phil Trans R Soc B, July 29, 2006; 361(1471): 1237 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wagoner, D. B. Hausman, and R. B. S. Harris Direct and indirect effects of leptin on preadipocyte proliferation and differentiation Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1557 - R1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Y. Raju, M. Zheng, K. H. Schuleri, A. C. Phan, D. Bedja, R. M. Saraiva, O. Yiginer, K. Vandegaer, K. L. Gabrielson, C. P. O'Donnell, et al. Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. PNAS, March 14, 2006; 103(11): 4222 - 4227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, J. J. Kuo, L. S. Tallam, J. Liu, and J. E. Hall Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? Hypertension, February 1, 2006; 47(2): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Esler and N. Eikelis Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol, January 1, 2006; 100(1): 11 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Straznicky, E. A. Lambert, G. W. Lambert, K. Masuo, M. D. Esler, and P. J. Nestel Effects of Dietary Weight Loss on Sympathetic Activity and Cardiac Risk Factors Associated with the Metabolic Syndrome J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5998 - 6005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, G. E Kilroy, T. M. Henagan, V. Prpic-Uhing, W. G. Richards, A. W. Bannon, R. L. Mynatt, and T. W. Gettys Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin FASEB J, September 1, 2005; 19(11): 1482 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Knudson, U. D. Dincer, C. Zhang, A. N. Swafford Jr., R. Koshida, A. Picchi, M. Focardi, G. M. Dick, and J. D. Tune Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H48 - H56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy J. Physiol., June 1, 2005; 565(2): 463 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Peeraully, J. R. Jenkins, and P. Trayhurn NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E331 - E339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fu, L. M. John, S. H. Adams, X. X. Yu, E. Tomlinson, M. Renz, P. M. Williams, R. Soriano, R. Corpuz, B. Moffat, et al. Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes Endocrinology, June 1, 2004; 145(6): 2594 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. da Silva, J. J. Kuo, and J. E. Hall Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin Hypertension, June 1, 2004; 43(6): 1312 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Eikelis, G. Lambert, G. Wiesner, D. Kaye, M. Schlaich, M. Morris, J. Hastings, F. Socratous, and M. Esler Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E744 - E752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Goodfriend and D. A. Calhoun Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy Hypertension, March 1, 2004; 43(3): 518 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Plut, C. Ribiere, Y. Giudicelli, and J.-P. Dausse Hypothalamic Leptin Receptor and Signaling Molecule Expressions in Cafeteria Diet-Fed Rats J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 544 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esler and D. Kaye Is Very High Sympathetic Tone in Heart Failure a Result of Keeping Bad Company? Hypertension, November 1, 2003; 42(5): 870 - 872. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Dobrian, S. D. Schriver, T. Lynch, and R. L. Prewitt Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity Am J Physiol Renal Physiol, October 1, 2003; 285(4): F619 - F628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vecchione, A. Aretini, A. Maffei, G. Marino, G. Selvetella, R. Poulet, V. Trimarco, G. Frati, and G. Lembo Cooperation Between Insulin and Leptin in the Modulation of Vascular Tone Hypertension, August 1, 2003; 42(2): 166 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Eikelis, M. Schlaich, A. Aggarwal, D. Kaye, and M. Esler Interactions Between Leptin and the Human Sympathetic Nervous System Hypertension, May 1, 2003; 41(5): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Coatmellec-Taglioni, J.-P. Dausse, Y. Giudicelli, and C. Ribiere Sexual Dimorphism in Cafeteria Diet-Induced Hypertension Is Associated with Gender-Related Difference in Renal Leptin Receptor Down-Regulation J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 362 - 367. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Hall The Kidney, Hypertension, and Obesity Hypertension, March 1, 2003; 41(3): 625 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis Eur. Heart J., January 2, 2003; 24(2): 198 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsumura, T. Tsuchihashi, K. Fujii, I. Abe, and M. Iida Central Ghrelin Modulates Sympathetic Activity in Conscious Rabbits Hypertension, November 1, 2002; 40(5): 694 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fortuno, A. Rodriguez, J. Gomez-Ambrosi, P. Muniz, J. Salvador, J. Diez, and G. Fruhbeck Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta Endocrinology, September 1, 2002; 143(9): 3555 - 3560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hausberg, D. A. Morgan, J. L. Mitchell, W. I. Sivitz, A. L. Mark, and W. G. Haynes Leptin Potentiates Thermogenic Sympathetic Responses to Hypothermia: A Receptor-Mediated Effect Diabetes, August 1, 2002; 51(8): 2434 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cettour-Rose and F. Rohner-Jeanrenaud The Leptin-Like Effects of 3-d Peripheral Administration of a Melanocortin Agonist Are More Marked in Genetically Obese Zucker (fa/fa) than in Lean Rats Endocrinology, June 1, 2002; 143(6): 2277 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carlyle, O. B. Jones, J. J. Kuo, and J. E. Hall Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity Hypertension, February 1, 2002; 39(2): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vecchione, A. Maffei, S. Colella, A. Aretini, R. Poulet, G. Frati, M. T. Gentile, L. Fratta, V. Trimarco, B. Trimarco, et al. Leptin Effect on Endothelial Nitric Oxide Is Mediated Through Akt-Endothelial Nitric Oxide Synthase Phosphorylation Pathway Diabetes, January 1, 2002; 51(1): 168 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsumura, T. Tsuchihashi, and I. Abe Central Human Cocaine- and Amphetamine-Regulated Transcript Peptide 55-102 Increases Arterial Pressure in Conscious Rabbits Hypertension, November 1, 2001; 38(5): 1096 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sonmez, U. Kisa, G. Uckaya, T. Eyileten, B. Comert, B. Koc, F. Kocabalkan, and M. Ozata Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 112 - 116. [Abstract] [PDF]
|
|
|
|
|
|
K. Matsumura, T. Tsuchihashi, and I. Abe Central Orexin-A Augments Sympathoadrenal Outflow in Conscious Rabbits Hypertension, June 1, 2001; 37(6): 1382 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. G. Correia, D. A. Morgan, W. I. Sivitz, A. L. Mark, and W. G. Haynes Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure Hypertension, March 1, 2001; 37(3): 936 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kuo, O. B. Jones, and J. E. Hall Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin Hypertension, February 1, 2001; 37(2): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Winters, Z. Mo, E. Brooks-Asplund, S. Kim, A. Shoukas, D. Li, D. Nyhan, and D. E. Berkowitz Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lepob) mice J Appl Physiol, December 1, 2000; 89(6): 2382 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsumura, T. Tsuchihashi, and I. Abe Central Cardiovascular Action of Neuropeptide Y in Conscious Rabbits Hypertension, December 1, 2000; 36(6): 1040 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Harrold, P. S. Widdowson, J. C. Clapham, and G. Williams Individual severity of dietary obesity in unselected Wistar rats: relationship with hyperphagia Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E340 - E347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. HORLICK, M. ROSENBAUM, M. NICOLSON, L. S. LEVINE, B. FEDUN, J. WANG, R. N. PIERSON Jr., and R. L. LEIBEL Effect of Puberty on the Relationship between Circulating Leptin and Body Composition J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2509 - 2518. [Abstract] [Full Text]
|
|
|
|
|
|
G. Paolisso, D. Manzella, N. Montano, A. Gambardella, and M. Varricchio Plasma Leptin Concentrations and Cardiac Autonomic Nervous System in Healthy Subjects with Different Body Weights J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1810 - 1814. [Abstract] [Full Text]
|
|
|
|
|
|
K. Matsumura, I. Abe, T. Tsuchihashi, and M. Fujishima Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1314 - R1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Uckaya, M. Ozata, A. Sonmez, C. Kinalp, T. Eyileten, N. Bingol, B. Koc, F. Kocabalkan, and I. C. Ozdemir Is Leptin Associated with Hypertensive Retinopathy? J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 683 - 687. [Abstract] [Full Text]
|
|
|
|
|
|
B. E. Levin and A. A. Dunn-Meynell Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R231 - R237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Williams, J. B. Chambers, O. L. May, R. P. Henderson, M. E. Rashotte, and J. M. Overton Concurrent reductions in blood pressure and metabolic rate during fasting in the unrestrained SHR Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R255 - R262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cittadini, C. S. Mantzoros, T. G. Hampton, K. E. Travers, S. E. Katz, J. P. Morgan, J. S. Flier, and P. S. Douglas Cardiovascular Abnormalities in Transgenic Mice With Reduced Brown Fat : An Animal Model of Human Obesity Circulation, November 23, 1999; 100(21): 2177 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Paolisso, M. R. Tagliamonte, M. Galderisi, G. A. Zito, A. Petrocelli, C. Carella, O. de Divitiis, and M. Varricchio Plasma Leptin Level Is Associated With Myocardial Wall Thickness in Hypertensive Insulin-Resistant Men Hypertension, November 1, 1999; 34(5): 1047 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Commins, D. J. Marsh, S. A. Thomas, P. M. Watson, M. A. Padgett, R. Palmiter, and T. W. Gettys Norepinephrine Is Required for Leptin Effects on Gene Expression in Brown and White Adipose Tissue Endocrinology, October 1, 1999; 140(10): 4772 - 4778. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Blumberg, K. Deaver, and R. F. Kirby Leptin disinhibits nonshivering thermogenesis in infants after maternal separation Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R606 - R610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Soderberg, B. Ahren, B. Stegmayr, O. Johnson, P.-G. Wiklund, L. Weinehall, G. Hallmans, and T. Olsson Leptin Is a Risk Marker for First-Ever Hemorrhagic Stroke in a Population-Based Cohort Stroke, February 1, 1999; 30(2): 328 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Glasow, A. Haidan, U. Hilbers, M. Breidert, J. Gillespie, W. A. Scherbaum, G. P. Chrousos, and S. R. Bornstein Expression of Ob Receptor in Normal Human Adrenals: Differential Regulation of Adrenocortical and Adrenomedullary Function by Leptin J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4459 - 4466. [Abstract] [Full Text]
|
|
|
|
|
|
D. Villarreal, G. Reams, R. H. Freeman, and A. Taraben Renal effects of leptin in normotensive, hypertensive, and obese rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R2056 - R2060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Flier What's in a Name? In Search of Leptin's Physiologic Role J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1407 - 1413. [Full Text]
|
|